Skip to main content
Premium Trial:

Request an Annual Quote

Kill Two Birds with Two Stones

In a recent post, blogger Biochem Belle of There and (Hopefully) Back Again shares her "decision to be less restrictive in my job search than I was a couple of years ago and to apply for both academic (postdoc) and industry positions." A choice that she says means, "among other things, having two versions of my CV." In drafting two versions of the same document — an "industry CV" as well as a "traditional" one — the blogger says she's discovered that "academics care about your pedigree and publications; industry wants to know what you can actually do — as in what methods and programs you actually have experience with." In a comment to this post, Rocket Scientista says that her industry CV makes her appear "much more impressive," than her academic one does. Reader Mkasprow responded to Biochem Belle's post on Twitter, saying: "For industry CV need to research the company so you can clearly specify how your skills help them."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.